Logo

Some Drugs and Herbal Products

Small book cover: Some Drugs and Herbal Products

Some Drugs and Herbal Products

Publisher: International Agency for Research on Cancer
Number of pages: 438

Description:
This volume of the IARC Monographs provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin (widely prescribed for the treatment of chronic heart failure), pioglitazone (used for the treatment of type 2 diabetes mellitus), and hydrochlorothiazide (used to treat hypertension).

Home page url

Download or read it online for free here:
Download link
(8.7MB, PDF)

Similar books

Book cover: Noninvasive Diagnostic Techniques for the Detection of Skin CancersNoninvasive Diagnostic Techniques for the Detection of Skin Cancers
by - Agency for Healthcare Research and Quality
The book provides a description of noninvasive imaging modalities in diagnosing cancerous tumors of the skin, proffers an analytic framework for assessing the applications of the imaging modalities, and summarizes the state of ongoing research.
(5746 views)
Book cover: Familial Cancer SyndromesFamilial Cancer Syndromes
by - NCBI
Written as a comprehensive reference, it will be a useful reference for clinicians and researchers. This release includes chapters on Peutz-Jeghers Syndrome, Familial Atypical Multiple Mole Melanoma Syndrome, and multiple endocrine neoplasia type 1.
(10877 views)
Book cover: Comprehensive Cervical Cancer Control: A Guide to Essential PracticeComprehensive Cervical Cancer Control: A Guide to Essential Practice
- World Health Organization
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. It outlines the complementary strategies, and highlights the need for collaboration across programmes, organizations and partners.
(4250 views)
Book cover: Non-Hodgkin's Lymphoma: Diagnosis and ManagementNon-Hodgkin's Lymphoma: Diagnosis and Management
- National Institute for Health and Care Excellence
This guideline aims to facilitate standardisation of practice in treating non-Hodgkin's lymphoma. But because of the rapid development of new therapies as a result of improved understanding of the disease, continual re-evaluation will be essential.
(3389 views)